-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Patients with alcoholic hepatitis had a lower short-term mortality rate when the Maddrey (mDF) differentiation function was improved.
but there is little data on long-term prognostics in such patients.
study was conducted to assess the 5-year survival rate of patients with Madrey's 32-point alcohol hepatitis and to identify predictive factors that affect long-term prognosis.
the study was a retrospective study conducted at two medical centres in Belgium and Austria.
included in 2 medical centers in the past due to the loss of compensation period liver disease admitted patients, patients of missing compensation period liver disease is manifested in the presence of ase abdominal water, liver encephalopathy or jaundice, all patients have received liver puncture biopsy, histology performance is fatty hepatitis, mDF -lt;32 points.
to record clinical and biological parameters during liver biopsies and information on the amount of alcohol consumed by patients during follow-up.
data is used for Cox risk scale regression models and survival analyses to determine factors associated with the 5-year survival rate.
121 patients, 64% were men, with an average age of 51.5 to 10.3 years, and 84% were patients with cirrhosis.
of the end-stage liver disease model and Madrey score were 14 (IQR 11.7 to 16.1) and 19 (IQR 11.1 to 24), respectively.
about 30 percent of patients absted from alcohol during follow-up.
1st, 6th, 12th, 24th and 60th months survival rates were 96.7 to 1.6%, 90.1 to 2.7%, 80.8 to 3.6%, 69.9 to 4.3% and 50.7 to 4.9%, respectively.
most patients die from liver-related diseases (80%).
multivariable analysis, baseline examination of patients for encephalopathy and alcohol withdrawal was a factor in predicting a patient's 5-year survival rate.
The 5-year survival rates of patients without hepatic encephalopathy and liver encephalopathy were 60.5 to 5.8% and 29.7 to 8.0%, respectively, and the five-year survival rates of patients who abstedred from alcohol and non-alcoholic diseases were 74.0 to 8.0% and 40.9 to 5.8%, respectively.
study showed that the five-year mortality rate for patients with alcohol-related hepatitis at Maddrey's 32 points was about 50 percent.
long-term prognosis in patients with hepatic encephalopathy and non-alcohol withdrawal at the baseline.
for this type of patient, new treatment strategies such as guiding patients to strictly abstned from alcohol should be considered during treatment.
.